Bacchus Therapeutics Inc.
Falls Church, VA
- UEI
- EWCHMK9ZL174
- CAGE
- 8HX06
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5505 Seminary Rd #1501n, Falls Church, VA 22041, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of lipogenesis inhibitors for tumor regression in renal cell carcinoma and other MYC-driven cancers | National Cancer Institute (NIH) | $1,216,296 |
Quick answers
Is Bacchus Therapeutics Inc. registered in SAM.gov?
Yes. Bacchus Therapeutics Inc.'s SAM.gov registration is active through March 4, 2027.
What is Bacchus Therapeutics Inc.'s most recent federal award?
Bacchus Therapeutics Inc.'s most recent federal grant award is Development of lipogenesis inhibitors for tumor regression in renal cell carcinoma and other MYC-driven cancers (R43CA256978), from National Cancer Institute (NIH), on August 1, 2021.
On GovTribe
See Bacchus Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors